# clm_B1C0CFC36770

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 7,341,996,000 United States dollar  
valid_from: 2010-03-31  
valid_to: 2010-06-30  
published: 2010-05-10  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_7D72B6AC9B7E  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 7,341,996,000 United States dollar", as of 2010-03-31 (until 2010-06-30). Claim clm_B1C0CFC36770, https://asof.is/claim/clm_B1C0CFC36770, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000119312510114616/0001193125-10-114616-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-05-10  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000119312510114616/0001193125-10-114616-index.htm (primary, SEC EDGAR 10-Q Q1 FY2010, published 2010-05-10)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 6,367,065,000 United States dollar | valid 2009-12-31 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_B1C0CFC36770](/claim/clm_B1C0CFC36770.md) | [clm_3163182F8E92](/claim/clm_3163182F8E92.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.